10-102834750-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000102.4(CYP17A1):​c.666+35T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.114 in 1,613,754 control chromosomes in the GnomAD database, including 13,765 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.14 ( 1803 hom., cov: 32)
Exomes 𝑓: 0.11 ( 11962 hom. )

Consequence

CYP17A1
NM_000102.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.231

Publications

128 publications found
Variant links:
Genes affected
CYP17A1 (HGNC:2593): (cytochrome P450 family 17 subfamily A member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. It has both 17alpha-hydroxylase and 17,20-lyase activities and is a key enzyme in the steroidogenic pathway that produces progestins, mineralocorticoids, glucocorticoids, androgens, and estrogens. Mutations in this gene are associated with isolated steroid-17 alpha-hydroxylase deficiency, 17-alpha-hydroxylase/17,20-lyase deficiency, pseudohermaphroditism, and adrenal hyperplasia. [provided by RefSeq, Jul 2008]
WBP1L (HGNC:23510): (WW domain binding protein 1 like) Predicted to enable ubiquitin protein ligase binding activity. Predicted to act upstream of or within CXCL12-activated CXCR4 signaling pathway; hemopoiesis; and positive regulation of protein ubiquitination. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
CYP17A1-AS1 (HGNC:31671): (CYP17A1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 10-102834750-A-G is Benign according to our data. Variant chr10-102834750-A-G is described in ClinVar as Benign. ClinVar VariationId is 1177609.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.33 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000102.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP17A1
NM_000102.4
MANE Select
c.666+35T>C
intron
N/ANP_000093.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP17A1
ENST00000369887.4
TSL:1 MANE Select
c.666+35T>C
intron
N/AENSP00000358903.3
CYP17A1
ENST00000489268.1
TSL:2
n.955T>C
non_coding_transcript_exon
Exon 3 of 3
CYP17A1
ENST00000639393.1
TSL:5
c.666+35T>C
intron
N/AENSP00000492651.1

Frequencies

GnomAD3 genomes
AF:
0.140
AC:
21353
AN:
151986
Hom.:
1798
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.186
Gnomad AMI
AF:
0.0175
Gnomad AMR
AF:
0.161
Gnomad ASJ
AF:
0.0905
Gnomad EAS
AF:
0.343
Gnomad SAS
AF:
0.225
Gnomad FIN
AF:
0.0871
Gnomad MID
AF:
0.0918
Gnomad NFE
AF:
0.0996
Gnomad OTH
AF:
0.139
GnomAD2 exomes
AF:
0.153
AC:
38333
AN:
250872
AF XY:
0.151
show subpopulations
Gnomad AFR exome
AF:
0.190
Gnomad AMR exome
AF:
0.210
Gnomad ASJ exome
AF:
0.0993
Gnomad EAS exome
AF:
0.341
Gnomad FIN exome
AF:
0.0918
Gnomad NFE exome
AF:
0.0959
Gnomad OTH exome
AF:
0.125
GnomAD4 exome
AF:
0.112
AC:
163288
AN:
1461650
Hom.:
11962
Cov.:
32
AF XY:
0.115
AC XY:
83595
AN XY:
727124
show subpopulations
African (AFR)
AF:
0.191
AC:
6411
AN:
33478
American (AMR)
AF:
0.210
AC:
9366
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.0959
AC:
2507
AN:
26134
East Asian (EAS)
AF:
0.329
AC:
13056
AN:
39698
South Asian (SAS)
AF:
0.235
AC:
20266
AN:
86234
European-Finnish (FIN)
AF:
0.0908
AC:
4847
AN:
53404
Middle Eastern (MID)
AF:
0.103
AC:
590
AN:
5714
European-Non Finnish (NFE)
AF:
0.0889
AC:
98829
AN:
1111898
Other (OTH)
AF:
0.123
AC:
7416
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
8295
16589
24884
33178
41473
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3864
7728
11592
15456
19320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.141
AC:
21398
AN:
152104
Hom.:
1803
Cov.:
32
AF XY:
0.142
AC XY:
10529
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.186
AC:
7728
AN:
41448
American (AMR)
AF:
0.161
AC:
2456
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.0905
AC:
314
AN:
3468
East Asian (EAS)
AF:
0.343
AC:
1776
AN:
5174
South Asian (SAS)
AF:
0.225
AC:
1083
AN:
4820
European-Finnish (FIN)
AF:
0.0871
AC:
923
AN:
10600
Middle Eastern (MID)
AF:
0.0918
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
0.0996
AC:
6775
AN:
68000
Other (OTH)
AF:
0.142
AC:
300
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
887
1774
2662
3549
4436
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
244
488
732
976
1220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.121
Hom.:
3397
Bravo
AF:
0.150
Asia WGS
AF:
0.247
AC:
858
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Deficiency of steroid 17-alpha-monooxygenase Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
3.2
DANN
Benign
0.67
PhyloP100
-0.23
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1004467; hg19: chr10-104594507; COSMIC: COSV64004950; COSMIC: COSV64004950; API